Literature DB >> 19048000

Sickle cell disease and the kidney.

Jon I Scheinman1.   

Abstract

The renal features of sickle cell disease (SCD) include some of the most common reasons for referral to nephrologists, such as hematuria, proteinuria, tubular disturbances and chronic kidney disease. Therapy of these conditions requires specialized knowledge of their distinct pathogenic mechanisms. Painless hematuria is usually benign--unless massive--and can be treated with hydration alone if renal medullary carcinoma has been ruled out. Tubular functional defects, which tend to reduce urinary concentrating capacity, generally require no specific treatment. Proteinuria might indicate the development of chronic sickle cell nephropathy, which can be treated effectively. Measurement of glomerular filtration rate in SCD is problematic, which makes identification and monitoring of chronic kidney disease difficult in patients with SCD. Although managing and predicting the outcomes of chronic kidney disease in the SCD setting is challenging, affected individuals do benefit from transplantation. This Review summarizes the presentation, processes, pathology, modifiers, diagnosis and treatment of the renal effects of SCD.

Entities:  

Mesh:

Year:  2008        PMID: 19048000     DOI: 10.1038/ncpneph1008

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  78 in total

1.  Excerpts from the United States Renal Data System 1996 Annual Data Report.

Authors: 
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

Review 2.  Pathophysiologic mechanisms of abnormal collecting duct function.

Authors:  S Sabatini
Journal:  Semin Nephrol       Date:  1989-06       Impact factor: 5.299

3.  Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia.

Authors:  José Herrera; Estela Avila; Crispín Marín; Bernardo Rodríguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2002-04       Impact factor: 5.992

4.  Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome.

Authors:  J C Jennette; L Charles; W Grubb
Journal:  Am J Kidney Dis       Date:  1987-12       Impact factor: 8.860

5.  Urographic changes in homozygous sickle cell disease.

Authors:  J C Odita; C I Ugbodaga; L A Okafor; L I Ojogwu; O A Ogisi
Journal:  Diagn Imaging       Date:  1983

Review 6.  Do glomerular hemodynamic adaptations influence the progression of human renal disease?

Authors:  A S Woolf; L G Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

7.  Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis.

Authors:  Y Yoshida; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

8.  Painful crises following renal transplantation in sickle cell anemia.

Authors:  D Spector; J B Zachary; S Sterioff; J Millan
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

9.  Recurrent hematuria in 4 white patients with sickle cell trait.

Authors:  E Oksenhendler; B Bourbigot; F Desbazeille; D Droz; C Choquenet; R Girot; P Jungers
Journal:  J Urol       Date:  1984-12       Impact factor: 7.450

10.  Demeclocycline-induced natriuresis and renal insufficiency: in vivo and in vitro studies.

Authors:  G L Braden; M A Geheb; A Shook; I Singer; M Cox
Journal:  Am J Kidney Dis       Date:  1985-05       Impact factor: 8.860

View more
  50 in total

1.  Detrimental effects of adenosine signaling in sickle cell disease.

Authors:  Yujin Zhang; Yingbo Dai; Jiaming Wen; Weiru Zhang; Almut Grenz; Hong Sun; Lijian Tao; Guangxiu Lu; Danny C Alexander; Michael V Milburn; Louvenia Carter-Dawson; Dorothy E Lewis; Wenzheng Zhang; Holger K Eltzschig; Rodney E Kellems; Michael R Blackburn; Harinder S Juneja; Yang Xia
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

2.  Changes in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Santosh L Saraf; Bruce I Gaynes; Victor R Gordeuk; Robert E Molokie; Mahnaz Shahidi
Journal:  Am J Nephrol       Date:  2015-08-05       Impact factor: 3.754

3.  Do the Eyes Reveal More Than Scleral Icterus in Sickle Cell Disease?

Authors:  Corinne A Pittman; Courtney D Fitzhugh
Journal:  Am J Nephrol       Date:  2015-08-05       Impact factor: 3.754

Review 4.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

5.  High prevalence of sickle cell trait in African Americans with ESRD.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Abhijit V Kshirsagar
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

6.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

Review 7.  Management of sickle cell disease in the community.

Authors:  Valentine Brousse; Julie Makani; David C Rees
Journal:  BMJ       Date:  2014-03-10

8.  Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Barry L Shulkin; Jane S Hankins; Russell E Ware
Journal:  Am J Hematol       Date:  2012-12-17       Impact factor: 10.047

9.  Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.

Authors:  Julia Z Xu; Melanie E Garrett; Karen L Soldano; Sean T Chen; Clary B Clish; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2018-09-27       Impact factor: 10.047

10.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.